This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
The FDA approved five novel small molecule drugs in neurology in 2021. Addressing a range of conditions from ADHD to…
Article
2 years ago ●
14 mins read
Context. “Compound 5g” (Incyte) is a selective cyclin-dependent kinase 2 (CDK2) inhibitor. Although CDK2 is a highly pursued cancer drug…
molecule
10 months ago ●
4 mins read
We asked the global drug discovery community to nominate and vote on their favorite molecule from 2021, and the results…
Article
2 years ago ●
11 mins read
Context. AZD1656 (AstraZeneca)is an oral glucokinase (GK) activator (GKA) for hyperglycemia in type 2 diabetes mellitus. Despite GK being first…
molecule
10 months ago ●
5 mins read
This article reviews the novel drugs approved by the FDA in February 2022. together with Dr. Naveed Yasin, Dr. Vinicius…
Article
2 years ago ●
6 mins read
Context. JNJ-64264681 (Janssen) is a covalent Bruton’s tyrosine kinase (BTK) inhibitor being developed for hematological malignancies. The first-in-class irreversible BTKi…
molecule
10 months ago ●
4 mins read
Load More
